baber/WOPTO huggingface dataset:
Patent CA-2252133-A1 (CA)
Inventor: GRANDE WOLFGANG
IPC: G08G1/123
Filed: 1998-11-25
Abstract: The invention concerns a method of controlling at least one transit stop display (1), whereby a vehicle (6) transmits its identification signal and its current location data to a control center (3), which calculates the estimated waiting time (5) until the vehicle (6) arrives at least at one stop (2), and controls the stop display (1) associated with to the respective stop (2) for the visual display of this waiting time (5).  To ensure that a switch-over or switch-off of the waiting time display takes place in the vicinity of the stop (2), it is provided that the vehicle (6) transmits a blanking message (9) with a small range x1, for example 100 meters, which triggers a switch-over of the stop display (1) to blanking (5a), when the vehicle (6) approaches the stop (2) within a distance of x2 ~ x1.
Patent CA-2252896-A1 (CA)
Title: Inactivation resistant factor viii
Inventor: AMANO KAGEHIRO
IPC: A61K38/43
Filed: 1997-04-24
Abstract: The present invention provides novel purified and isolated nucleic acid sequences encoding procoagulant-active FVIII proteins. The nucleic acid sequences of the present invention encode amino acid sequences corresponding to known human FVIII sequences, wherein residue Phe309 is mutated. The nucleic acid sequences of the present invention also encode amino acid sequences corresponding to known human FVIII sequences, wherein the APC cleavage sites, Arg336 and Ile562, are mutated. The nucleic acid sequences of the prsent invention further encode amino acid sequences corresponding to known human FVIII sequences, wherein the B-domain is deleted, the von Willebrand factor binding site is deleted, a thrombin cleavage site is mutated and an amino acid sequence spacer is inserted between the A2- and A3-domains. Methods of producing the FVIII proteins of the invention, nucleotide sequences encoding such proteins, pharmaceutical compositions containing the nucleotide sequences or proteins, as well as methods of treating patients suffering from hemophilia, are also provided.
Patent CA-2253541-A1 (CA)
Title: Human phospholipase inhibitor
Inventor: HAWKINS PHILLIP R
IPC: A61K38/00
Filed: 1997-05-09
Abstract: The present invention provides a polynucleotide (gipl) the partial sequence for which was initially isolated from a THP-1 cDNA library and which identifies and encodes a novel human phospholipase inhibitor (GIPL). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding GIPL. The invention also provides for the use of purified GIPL and its agonists in pharmaceutical compositions for the treatment of diseases associated with the abnormal or excess phospholipase activity. Additionally, the invention provides for the use of antisense molecules to gipl or inhibitors of GIPL in pharmaceutical compositions for the prevention of pregnancy or treatment of Alzheimer's disease. The invention also describes diagnostic assays which utilize diagnostic compositions comprising the polynucleotide, fragments or the complement thereof, which hybridize with the genomic sequence or the transcript of gipl, or anti-GIPL antibodies which specifically bind to the polypeptide, GIPL.
Patent CA-2254026-A1 (CA)
Inventor: GREWE TIMOTHY M
IPC: F02D29/06
Filed: 1998-11-12
Abstract: An electric vehicle is controlled to conform its operation to that of a conventional internal-combustion-engine powered vehicle. In some embodiments, the charging of the batteries by the auxiliary source of electricity and from dynamic braking is ramped in magnitude when the batteries lie in a state of charge between partial charge and full charge, with the magnitude of the charging being related to the relative state of charge of the battery. The deficiency between traction motor demand and the energy available from the auxiliary electrical source is provided from the batteries in an amount which depends upon the state of the batteries, so that the full amount of the deficiency is provided when the batteries are near full charge, and little or no energy is provided by the batteries when they are near a discharged condition. At charge states of the batteries between near-full-charge and near-full-discharge, the batteries supply an amount of energy which depends monotonically upon the charge state. Charging of the batteries from the auxiliary source is reduced during dynamic braking when the batteries are near full charge. Control of the amount of energy returned during dynamic braking may be performed by control of the transducing efficiency of the traction motor operated as a generator.
Patent CA-2255122-A1 (CA)
Title: Improvements in ms/ms methods for a quadrupole/time of flight tandem mass spectrometer
Inventor: CHERNUSHEVICH IGOR
IPC: H01J49/42
Filed: 1998-12-04
Abstract: There is provided a method of effecting mass analysis on an ion stream, the method comprising passing the ion stream through a first mass resolving spectrometer, to select parent ions having a first desired mass -to--charge ratio. The parent ions are them subject to collision-induced dissociation (CID) to generate fragment ions, and the fragment ions and any remaining parent ions are trapped; the CID and trapping can be carried out together in a linear ion trap. Periodically pulses of the trapped ions are released into a time of flight (TOF) instrument to determine the mass -to--charge ratio of the ions. The delay between the release of the pulses and the initiation of the push-pull pulses of the TOF instrument are adjusted to maximize the duty cycle efficiency and hence the sensitivity for a selected ions with a desired mass-to-charge ratio. This technique can be used to optimize the performance for a parent ion scan, and MRM scan or a neutral loss scan.
Patent CA-2255888-A1 (CA)
Inventor: WESTBROOK SIMON L
IPC: A61K31/00
Filed: 1997-05-22
Abstract: This invention relates to immunogenic, non-naturally occurring peptides and immunologically reactive molecules thereto which modulate the activity of hormones or the receptors therefor. These peptides are based on portions of somatostatin, somatostatin receptors and insulin-like growth factor binding protein. Methods of modulating hormonal activity in an animal and compositions therefor are also contemplated.
Patent CA-2256432-A1 (CA)
Inventor: SIESS THORSTEN
IPC: A61M60/88
Filed: 1998-03-31
Abstract: The invention relates to a pump device comprising a first pump (10a) and a second pump (10b). The suction end of the first pump (10a) can be introduced into the left ventricle (42) of the heart, whilst the delivery end is positioned in the aorta (40), and the suction end of the second pump (10b) is arranged in the right atrium (43) whilst the delivery end is positioned in the pulmonary artery (47). Both pumps (10a, 10b) are driven interdependently by a single control unit, the first pump (10a) assumes a lead function while the second pump (10b) only pumps around 90 % of the volume flow of said first (10a) pump. Pressure sensors on the pumps serve to detect the pressure difference between the suction end and the delivery end of a pump and to determine the volume flow. Both pumps are introduced into the heart without the ventricle having to be opened.
Patent CA-2257482-A1 (CA)
Inventor: SHANBROM EDWARD
IPC: A61P31/04
Filed: 1997-06-20
Abstract: La présente invention concerne des milieux pour inactiver des agents pathogènes découverts dans des fluides biologiques contenant des protéines. Ces milieux préservent l'intégrité structurale et l'activité biologique des protéines labiles tout en présentant simultanément une puissante activité désinfectante. Ces milieux sont constitués de milieux chromatographiques iodés, notamment des milieux d'échange ionique. L'invention concerne également des méthodes pour désinfecter des fluides biologiques.
Patent CA-2258593-A1 (CA)
Inventor: NUDELMAN ABRAHAM
IPC: A61P17/06
Filed: 1997-07-01
Abstract: L'invention concerne de nouveaux composés de rétinoyloxy-alkylène butyrate (substitué) et des compositions pharmaceutiques contenant lesdits composés, ainsi que des méthodes permettant de traiter, de prévenir le cancer ou de soulager les symptômes du cancer et d'autres maladies prolifératives chez un sujet ayant besoin d'un tel traitement. La méthode consiste à administrer à un patient ces composés, leurs sels ou leurs promédicaments pharmaceutiquement acceptables. Les composés de l'invention sont également utiles dans des méthodes permettant d'inhiber l'histone déacétylase, d'atténuer les rides, de traiter ou de soulager les troubles dermatologiques, de favoriser la cicatrisation, de traiter les ulcères cutanés et les troubles gastro-intestinaux.
Patent CA-2260193-A1 (CA)
Inventor: BRZYTWA TADEK C
IPC: F28F27/00
Filed: 1997-06-23
Abstract: A rotary regenerative air preheater (10) having a linear scan hot spot detection system (38). This linear scan hot spot detection system (38) has a linear rail assembly (44) generally extending from the center to the periphery of the rotor (14) cavity. The rail assembly (44) preferably supports two carriage assemblies (54) for linear motion thereon. A drive mechanism (58) located on the exterior wall of the air preheater (10) shuttles the carriages (54) between the central portion and the peripheral portion of the rotor (14) cavity. Each carriage assembly (54) supports a single infrared sensor assembly head (66) for detecting hot spots on the air preheater rotor (14). The linear reciprocating motion of the two carriages (54) results in complete detection coverage for the rotating air preheater rotor (14).
Patent CA-2260979-A1 (CA)
Inventor: KNUFMANN HEINRICH
IPC: B30B9/32
Filed: 1997-01-17
Abstract: In order to reduce assembly and dismantling times whilst retaining the properties of mass-produced components, the invention proposes a scrap cutter transport unit with a base frame (1) for accommodating assemblies both in their transportation and their operating states. During transportation, the transport unit accommodates the cutter stand (2) in the removed state so that it can pivot about a point (3). A second transport unit is formed by the press frame which comprises auxiliary supports for transportation purposes.
Patent CA-2261857-A1 (CA)
Title: Appareils pour traitements d'orthopedie fonctionnelle dento-faciale et parodontologie
Inventor: MATHIEU ROGRIGUE
IPC: A61C7/08
Filed: 1997-07-29
Abstract: Appareils correcteurs pour traitement d'orthopédie dento-faciale fonctionnelle et parodontologie, en matériau naturel ou synthétique, souple et alimentaire, constitués, d'une façon générale, d'une double gouttière (ou augette), ces deux gouttières affectant extérieurement, en plan, la forme d'un U évasé et étant séparées par une cloison épaisse horizontale (3). Ils sont caractérisés en ce que: (a) la partie de la gouttière destinée à recevoir les incisives inférieures présente une courbure limitée et a, de préférence, la forme d'un canal droit (4); (b) la longueur du canal destiné à recevoir les incisives inférieures est prévue suffisante pour que les quatre incisives inférieures aient la place nécessaire pour s'y installer; (c) la hauteur des parois latérales linguale (2) et vestibulaire (1) délimitant le canal destiné à recevoir les incisives inférieures (4), depuis la cloison épaisse horizontale (3), est au moins égale à la hauteur des incisives jusqu'à leur collet.
Patent CA-2262765-A1 (CA)
Inventor: BARRY DAVID WALTER
IPC: A61K31/7072
Filed: 1997-06-23
Abstract: The present ivention relates to therapeutic combinations of [3R*(1R*,2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2-hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (141W94), 3'-azido-3'-deoxythymidine (zidovudine) and (1S,4R)-cis-4-[2-amino-6(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol (1592U89) which have anti-HIV activity. The present invention is also concerned with pharmaceutical compositions containing said combinations and their use in the treatment of HIV infections including infections with HIV mutants bearing resistance to nucleoside and/or non-nucleoside inhibitors.
Patent CA-2263868-A1 (CA)
Inventor: LASNE YVES
IPC: A47B81/00
Filed: 1997-08-15
Abstract: The invention provides a storage and display unit (1) for homeopathic medicines having a front, a back, and two sides, comprising a plurality of elongate racks (4) slidably mounted side by side in the unit (1) for slidable lengthwise withdrawal forwards out of the front of the unit (1), each rack (4) being divided both vertically and horizontally to form a plurality of stacks of subdivisions (6) arranged in rows within the respective rack (4), each subdivision (6) having access from at least one side of the respective rack (4) and being adapted to receive at least one elongate container (9) containing a homeopathic medicine with the containers (9) in each stack of subdivisions (6) being arranged with their length extending in the direction of withdrawal of the respective rack (4) from the unit (1).
Patent CA-2264558-A1 (CA)
Inventor: WEIDNER ECKHARD
IPC: C11C3/04
Filed: 1997-09-11
Abstract: L'invention concerne un procédé de préparation d'esters d'acide gras à partir de triglycéride d'acide gras et notamment à partir de graisses et huiles animales et végétales, par transestérification avec un alcool inférieur monovalent en présence d'un catalyseur homogène ou hétérogène. Selon l'invention, l'ester d'acide gras formé est extrait du mélange réactionnel avec un agent d'extraction proche du point critique. On peut ainsi obtenir des esters d'acide gras avec un rendement élevé et une très grande pureté. On utilise de préférence comme agent d'extraction un gaz à faible pression qui présente, à 20 ·C, une température réduite, s'élevant environ à 0,7 ·C, de préférence supérieure ou égale à 0,7 ·C. Les agents d'extraction préférés sont le dioxyde de carbone, le propane, le butane, le diméthyléther, l'acétate d'éthyle ou leurs mélanges.
Patent CA-2265845-A1 (CA)
Title: Ic module, ic card, sealing resin for ic module, and method for manufacturing ic module
Inventor: FUKUSHIMA YOSHIKAZU
IPC: H01L23/31
Filed: 1998-07-16
Abstract: An IC card (10) comprises a card base (20) and an IC module (11) mounted in a recessed portion (21) of the card base (20). The IC module (11) comprises a board (12), a terminal portion (13) provided on one surface of the board (12), and an IC chip (14) provided on the other surface of the board (12). The terminal portion (13) and the IC chip (14) are connected by a wire (15), and the IC chip (14) and the wire (15) are covered by a resin-sealed portion (16).  The resin-sealed portion (16) contains a resin component and a solid component, and the weight ratio of the resin component to the solid component near the outermost surface is 90:10 to 100:0.
Patent CA-2273121-A1 (CA)
Inventor: CAVANAGH JAMES
IPC: C11D7/26
Filed: 1999-05-27
Abstract: Compositions and methods for removing rust stains from hard surfaces. The compositions contain acidic cleaning constituents, particularly oxalic acid, and abrasive constituents including pumice. The compositions contain reduced amounts of respirable silica.
Patent CA-2274891-A1 (CA)
Inventor: MORGAN AVERY A
IPC: G01C19/72
Filed: 1997-11-21
Abstract: In a fiber optic gyro (FOG) with a photo-diode phase detector that produces a detector signal that is supplied to an A/D converter to generate a FOG information signal for use in a signal processor to produce a FOG control signal based on FOG controller equations, the photo-diode out is summed with a feedback signal from the signal processor to reduce a DC offset in the input to the A/D converter.
Patent CA-2276606-A1 (CA)
Title: Method of treating prostatic diseases using active vitamin d analogues
Inventor: MAZESS RICHARD B
IPC: A01N45/00
Filed: 1997-12-10
Abstract: The invention provides therapeutic methods for inhibiting, ameliorating or alleviating the hyperproliferative cellular activity of diseases of the prostate, e.g., prostatic cancer and prostatic hyperplasia, which includes administering to a patient in need thereof an active vitamin D analogue. Cell differentiation is promoted, induced or enhanced without causing to the patient dose-limiting hypercalcemia and hypercalciuria.
Patent CA-2277896-A1 (CA)
Inventor: GUNASEKARAN SUBRAMANIAN
IPC: A61P17/02
Filed: 1998-01-12
Abstract: The present invention relates to methods for preparing collagen, especially type I collagen. In particular, the present invention provides methods for the preparation of collagen suitable for biomedical and veterinary applications.  The collagen prepared according to the present invention provides numerous desirable characteristics for applications such as implantation, transplantation, and grafting.
Patent CA-2279726-A1 (CA)
Inventor: MATLOCK GORDON E
IPC: B27F7/15
Filed: 1999-08-05
Abstract: An end plating machine for a wood tie having opposite ends comprising a frame including horizontally spaced-apart first and second end frames with the frame including tie in-feed and out-feed portions. A conveyor is provided for positioning a tie between the end frames. First and second tie clampers are positioned adjacent the first and second end frames for clamping the ends of a tie positioned therebetween. First and second power rams are mounted on the first and second end frames, respectively, for driving an end plate into the ends of the tie while the tie is being clamped by the first and second tie clampers. First and second end plate hoppers are positioned on the first and second end frames, respectively, for supporting a plurality of end plates therein. First and second end plate transporters are mounted on the first and second end frames, respectively, for successively transporting individual end plates from the hopper to a position adjacent the ends of the tie positioned in the tie clampers so that the power rams may drive the end plates into the ends of the tie.
Patent CA-2280507-A1 (CA)
Inventor: HAEKLI HARRI
IPC: A23L33/21
Filed: 1998-02-05
Abstract: Substance for reduction of absorption of lipids and for reduction of serum cholesterol content in mammals comprises microcrystalline chitosan. The microcrystalline chitosan can be administered orally in food products or in dose units containing a predetermined amount of microcrystalline chitosan. The microcrystalline chitosan has an average particle size not higher than 100 .mu.m.
Patent CA-2281386-A1 (CA)
Title: Apparatus for producing a photographic picture
Inventor: FRICK BEAT
IPC: G03B27/32
Filed: 1999-09-07
Abstract: The invention relates to an apparatus for producing a photographic picture on a copy material, whereby an exposure arrangement with a projection optics is provided for the production of the photographic picture which includes a mirror matrix with individually movable mirrors, whereby the exposure arrangement includes a wide-band light source, for example a halogen light source, whereby a filter arrangement is positioned in the light beam between the light source and the mirror matrix in order to filter out or let pass specific spectral regions or specific amounts of light.
Patent CA-2281968-A1 (CA)
Title: Air knife apparatus for removing an airlaid article from a deposition cavity
Inventor: FUNG PAUL
IPC: A61F13/15
Filed: 1990-05-24
Abstract: An air knife apparatus is disclosed for removing an airlaid article from a deposition cavity. The article is formed into an absorbent core for products such as a sanitary napkin, a diaper or the like. The knife apparatus comprises the control of a stream of compressed air to urge the airlaid article against transfer apparatus. The compressed air enters the apparatus at a pressure of between about 4 psi and 20 psi.
Patent CA-2285304-A1 (CA)
Title: Uniformly wound rolls of soft tissue sheets having high bulk
Inventor: KARLSSON TOMMY ROLF
IPC: B65H18/28
Filed: 1998-06-26
Abstract: A uniformly wound parent roll of soft, high bulk tissue has greater uniformity in sheet basis weight, machine direction stretch and bulk when compared to parent rolls wound by conventional winding methods. The method involves carrying the tissue sheet on a relatively air impermeable transfer belt (18) which traverses an unsupported span between two winding drums. The sheet (15) is transferred from the transfer belt to the parent roll (25) as the parent roll is urged against the sheet/transfer belt at a point within the unsupported span. The resulting deflection of the transfer belt is detected and, in response, the reel spool position is controllably changed to maintain the deflection within predetermined limits. The tension of the sheet is controlled by the predetermined differential speed between the outer most surface of the parent roll and the transfer belt.
Patent CA-2286370-A1 (CA)
Inventor: DOVE KENNETH W
IPC: G04G15/00
Filed: 1999-10-14
Abstract: A programmable timer device for selectively supplying or denying electrical power to an appliance such as a television, VCR or a computer monitor has a housing with a lockable lid, a recess provided in the housing to receive a power cord of the appliance, a yoke provided in the housing preventing unauthorized removal of the power cord, programmable control means for controlling the times when the appliance receives electrical power supplied through the power cord via the device, and a dedicated override actuator which is enabled by entering a code. The programmable control means is inaccessible when the lid is closed but the dedicated override actuator and a keypad for entry of the enabling code are accessible through openings in the lid when the lid is closed.
Patent CA-2286631-A1 (CA)
Title: Solid compositions suitable for oral administration comprising l-carnitine or an alkanoyl-l-carnitinecholine tartrate
Inventor: SANTANIELLO MOSE
IPC: A23K1/16
Filed: 1998-04-08
Abstract: Stable and non hygroscopic salts consisting of L-carnitine or alkanoyl-L-carnitine choline tartrate are disclosed which are suitable for preparing solid compositions useful as dietary/nutritional supplements for human use and as fodder supplement for veterinary purposes.
Patent CA-2290110-A1 (CA)
Title: Embout elastique pour baton de sport
Inventor: SAVARD STEPHANE
IPC: A63B69/00
Filed: 1999-11-04
Abstract: Un embout élastique pour bâton de sport qui comprend la partie du desso us qui forme un angle avec le sol , une partie avant élastique et une section surélever caractérisé par un trou qui permet d' introduire le bâton par le dessus de l' embout. Le bâton peut disposer d'une poignée et d' une courroie à l'autre bout du bâton.
Patent CA-2292111-A1 (CA)
Title: Isocyanate-based polymer foam and process for production thereof
Inventor: DULEY JOHN A
IPC: C08G18/48
Filed: 1999-12-13
Abstract: An isocyanate-based polymer foam comprising an isocyanate-based polymer foam matrix having disposed therein a particulate material having an enthalpy of endothermic phase transition of at least about 50 J/g. A process for producing the foam is also described. During the process, the particulate material acts as a heat sink and will undergo an endothermic phase change by absorbing a significant portion of the heat of reaction liberated during the process. This improves the safety of the process by lowering the maximum exotherm experienced by the foam and/or improves product properties.
Patent CA-2292268-A1 (CA)
Inventor: YU ALFRED
IPC: B63B43/08
Filed: 1999-12-16
Abstract: A ballast system for a sailing boat includes an elongate body having a first end and a second end. A mounting is provided at the first end of the elongate body for suspending the elongate body from a hull of a sailing boat. A ballast weight is positioned at the second end of the elongate body.      A motor and gear assembly are provided for moving the second end of the elongate body relative to the hull of the sailing boat. The described ballast system decreases the amount of ballast weight required without sacrificing the safety of operation of the sail boat. The decrease in ballast weight, decreases the over all displacement of the sail boat, and permits increased speed.